Genomic characterization of invasive typhoidal and non-typhoidal Salmonella in southwestern Nigeria.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
02
02
2022
accepted:
03
08
2022
revised:
08
09
2022
pubmed:
27
8
2022
medline:
14
9
2022
entrez:
26
8
2022
Statut:
epublish
Résumé
Salmonellosis causes significant morbidity and mortality in Africa. Information on lineages of invasive Salmonella circulating in Nigeria is sparse. Salmonella enterica isolated from blood (n = 60) and cerebrospinal fluid (CSF, n = 3) between 2016 and 2020 from five tertiary hospitals in southwest Nigeria were antimicrobial susceptibility-tested and Illumina-sequenced. Genomes were analysed using publicly-available bioinformatic tools. Isolates and sequence types (STs) from blood were S. Typhi [ST1, n = 1 and ST2, n = 43] and invasive non-typhoidal Salmonella (iNTS) (S. Enteritidis [ST11, n = 7], S. Durham [ST10, n = 2], S. Rissen [ST8756, n = 2], S. Chester [ST2063, n = 1], S. Dublin [ST10, n = 1], S. Infantis [ST603, n = 1], S. Telelkebir [ST8757, n = 1] and S. Typhimurium [ST313, n = 1]). S. Typhi ST2 (n = 2) and S. Adabraka ST8757 (n = 1) were recovered from CSF. Most S. Typhi belonged to genotype 3.1.1 (n = 44), carried an IncY plasmid, had several antibiotic resistance genes (ARGs) including blaTEM-1 (n = 38), aph(6)-Id (n = 32), tet(A) (n = 33), sul2 (n = 32), dfrA14 (n = 30) as well as quinolone resistance-conferring gyrA_S83Y single-nucleotide polymorphisms (n = 37). All S. Enteritidis harboured aph(3")-Ib, blaTEM-1, catA1, dfrA7, sul1, sul2, tet(B) genes, and a single ARG, qnrB19, was detected in S. Telelkebir. Typhoidal toxins cdtB, pltA and pltB were detected in S. Typhi, Rissen, Chester, and Telelkebir. Most invasive salmonelloses in southwest Nigeria are vaccine-preventable infections due to multidrug-resistant, West African dominant S. Typhi lineage 3.1.1. Invasive NTS serovars, including some harbouring typhoidal toxin or resistance genes, represented a third of the isolates emphasizing the need for better diagnosis and surveillance.
Sections du résumé
BACKGROUND
Salmonellosis causes significant morbidity and mortality in Africa. Information on lineages of invasive Salmonella circulating in Nigeria is sparse.
METHODS
Salmonella enterica isolated from blood (n = 60) and cerebrospinal fluid (CSF, n = 3) between 2016 and 2020 from five tertiary hospitals in southwest Nigeria were antimicrobial susceptibility-tested and Illumina-sequenced. Genomes were analysed using publicly-available bioinformatic tools.
RESULTS
Isolates and sequence types (STs) from blood were S. Typhi [ST1, n = 1 and ST2, n = 43] and invasive non-typhoidal Salmonella (iNTS) (S. Enteritidis [ST11, n = 7], S. Durham [ST10, n = 2], S. Rissen [ST8756, n = 2], S. Chester [ST2063, n = 1], S. Dublin [ST10, n = 1], S. Infantis [ST603, n = 1], S. Telelkebir [ST8757, n = 1] and S. Typhimurium [ST313, n = 1]). S. Typhi ST2 (n = 2) and S. Adabraka ST8757 (n = 1) were recovered from CSF. Most S. Typhi belonged to genotype 3.1.1 (n = 44), carried an IncY plasmid, had several antibiotic resistance genes (ARGs) including blaTEM-1 (n = 38), aph(6)-Id (n = 32), tet(A) (n = 33), sul2 (n = 32), dfrA14 (n = 30) as well as quinolone resistance-conferring gyrA_S83Y single-nucleotide polymorphisms (n = 37). All S. Enteritidis harboured aph(3")-Ib, blaTEM-1, catA1, dfrA7, sul1, sul2, tet(B) genes, and a single ARG, qnrB19, was detected in S. Telelkebir. Typhoidal toxins cdtB, pltA and pltB were detected in S. Typhi, Rissen, Chester, and Telelkebir.
CONCLUSION
Most invasive salmonelloses in southwest Nigeria are vaccine-preventable infections due to multidrug-resistant, West African dominant S. Typhi lineage 3.1.1. Invasive NTS serovars, including some harbouring typhoidal toxin or resistance genes, represented a third of the isolates emphasizing the need for better diagnosis and surveillance.
Identifiants
pubmed: 36026470
doi: 10.1371/journal.pntd.0010716
pii: PNTD-D-22-00152
pmc: PMC9455843
doi:
Substances chimiques
Anti-Bacterial Agents
0
Interleukin-1 Receptor-Like 1 Protein
0
Typhoid-Paratyphoid Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0010716Subventions
Organisme : Wellcome Trust
ID : 206194
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L00464X/1
Pays : United Kingdom
Organisme : Department of Health
ID : 16_136_111
Pays : United Kingdom
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Lett Appl Microbiol. 2018 Apr;66(4):352-359
pubmed: 29397031
Front Microbiol. 2021 Jul 29;12:704152
pubmed: 34394052
Clin Infect Dis. 2015 Nov 1;61 Suppl 4:S235-40
pubmed: 26449937
PLoS Negl Trop Dis. 2019 Sep 12;13(9):e0007620
pubmed: 31513580
Nat Rev Microbiol. 2014 Sep;12(9):599-611
pubmed: 25023120
Genome Res. 2020 Jan;30(1):138-152
pubmed: 31809257
Int J Med Microbiol. 2004 Sep;294(2-3):95-102
pubmed: 15493819
Microb Genom. 2021 Nov;7(11):
pubmed: 34812716
BMC Genomics. 2011 Aug 22;12:425
pubmed: 21859443
Antimicrob Agents Chemother. 2019 Dec 20;64(1):
pubmed: 31636071
PLoS Negl Trop Dis. 2016 Aug 11;10(8):e0004857
pubmed: 27513951
PLoS Pathog. 2019 Apr 5;15(4):e1007704
pubmed: 30951565
Nat Commun. 2021 May 17;12(1):2879
pubmed: 34001879
Clin Infect Dis. 2019 Oct 30;69(Suppl 6):S466-S473
pubmed: 31665773
PLoS Negl Trop Dis. 2018 Jan 12;12(1):e0006156
pubmed: 29329299
Clin Infect Dis. 2019 Oct 30;69(Suppl 6):S422-S434
pubmed: 31665779
Emerg Infect Dis. 2015 Jun;21(6):
pubmed: 25860298
Antibiotics (Basel). 2020 Sep 30;9(10):
pubmed: 33007986
Genome Res. 2009 Dec;19(12):2279-87
pubmed: 19901036
Eur J Clin Microbiol Infect Dis. 2016 Dec;35(12):1913-1922
pubmed: 27562406
PLoS Negl Trop Dis. 2017 Feb 27;11(2):e0005376
pubmed: 28241011
Vet Res. 2011 Feb 14;42:34
pubmed: 21324103
J S Afr Vet Assoc. 2018 Nov 07;89(0):e1-e10
pubmed: 30456978
PLoS One. 2021 Jun 17;16(6):e0253312
pubmed: 34138936
PLoS Negl Trop Dis. 2019 Oct 14;13(10):e0007782
pubmed: 31609964
Microbiology (Reading). 2005 Dec;151(Pt 12):3957-3968
pubmed: 16339940
Zoonoses Public Health. 2015 Mar;62(2):151-8
pubmed: 24931512
Front Med (Lausanne). 2019 Jun 18;6:131
pubmed: 31275940
J S Afr Vet Assoc. 2010 Mar;81(1):37-44
pubmed: 20649153
Vaccines (Basel). 2021 Feb 17;9(2):
pubmed: 33671372
Nat Genet. 2012 Nov;44(11):1215-21
pubmed: 23023330
Lancet. 2012 Jun 30;379(9835):2489-2499
pubmed: 22587967
Nat Rev Microbiol. 2015 Apr;13(4):206-16
pubmed: 25749454
Hum Vaccin Immunother. 2019;15(6):1421-1426
pubmed: 30081708
Clin Infect Dis. 2021 Dec 1;73(Suppl_4):S308-S315
pubmed: 34850837
PLoS Negl Trop Dis. 2016 Sep 22;10(9):e0004781
pubmed: 27657909
J Infect Dev Ctries. 2021 Sep 30;15(9):1222-1235
pubmed: 34669589
Nat Genet. 2016 Oct;48(10):1211-1217
pubmed: 27548315
Nat Commun. 2018 Nov 30;9(1):5094
pubmed: 30504848
Pathog Dis. 2014 Nov;72(2):95-103
pubmed: 24891290
J Infect. 2008 Jun;56(6):413-22
pubmed: 18474400
Clin Infect Dis. 2010 Mar 15;50(6):882-9
pubmed: 20158401
Lancet Glob Health. 2014 Oct;2(10):e570-80
pubmed: 25304633
Lancet Infect Dis. 2010 Jun;10(6):417-32
pubmed: 20510282
Gut Pathog. 2015 Jul 24;7:19
pubmed: 26207144
Sci Rep. 2017 Jun 1;7(1):2653
pubmed: 28572615
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Clin Microbiol Infect. 2014 Feb;20(2):O109-16
pubmed: 23992040
BMC Genomics. 2019 Jan 31;20(1):99
pubmed: 30704413
J Vet Med Sci. 2020 May 15;82(5):580-584
pubmed: 32188802
Res Microbiol. 2014 Sep;165(7):526-30
pubmed: 25049166
Clin Infect Dis. 2015 Nov 1;61 Suppl 4:S325-31
pubmed: 26449948
PLoS Pathog. 2012;8(6):e1002776
pubmed: 22737074
Clin Infect Dis. 2006 Feb 1;42(3):377-82
pubmed: 16392084
Infect Immun. 2003 Feb;71(2):629-40
pubmed: 12540539
BMC Genomics. 2022 Mar 19;23(1):217
pubmed: 35303794
Microbes Infect. 2000 Feb;2(2):145-56
pubmed: 10742687
BMJ Glob Health. 2021 Aug;6(8):
pubmed: 34341020
Rev Inst Med Trop Sao Paulo. 2019 Jul 22;61:e36
pubmed: 31340248
J Infect Dev Ctries. 2008 Aug 30;2(4):267-71
pubmed: 19741287
Clin Infect Dis. 2019 Oct 30;69(Suppl 6):S413-S416
pubmed: 31665775